| Serial Number | 79301197 |
| Word Mark | MITOINDEX |
| Filing Date | Sunday, October 18, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, November 22, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medical diagnostic testing, monitoring and reporting services; medical diagnostic services, namely, assessing the level of healthy mitochondria or mutated mitochondria, mitochondrial activity; medical diagnostic testing and reporting services in the fields of DNA sequencing, DNA and RNA analysis, and genetic analysis; medical diagnostic testing and reporting services, namely, protein sequencing services and protein analysis; medical consultancy services in relation to diagnostic and assay products; consulting services in the field of diagnostic medical testing |
| Goods and Services | Scientific research in the field of assessing the level of healthy mitochondria and mutated mitochondria, mitochondrial activity; medical research relating to assessing the level of healthy mitochondria and mutated mitochondria, mitochondrial activity; scientific advisory services in the fields of technical diagnostic products, chemistry, biotechnology and biochemistry for assessing the level of healthy mitochondria and mutated mitochondria, and mitochondrial related activity; biotechnology and biological research and testing of the level of healthy mitochondria and or mutated mitochondria, mitochondrial activity; scientific research services, namely, gene analysis and sequencing, DNA analysis and sequencing, and nucleic acid analysis; scientific research services, namely, protein analysis and protein sequencing services; software as a service (saas) in relation to diagnostic and assay products; software as a service (saas) featuring software for assessing the level of healthy mitochondria and mutated mitochondria, mitochondrial activity; consulting services in the fields of laboratory testing and diagnostics |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 4, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 4, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Minovia Therapeutics Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | IL |
| Event Date | Event Description |
| Saturday, February 3, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, December 11, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, November 22, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, November 22, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 22, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, November 22, 2022 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Tuesday, November 22, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, June 21, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, June 1, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 1, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, May 3, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, May 3, 2022 | FINAL REFUSAL E-MAILED |
| Tuesday, May 3, 2022 | FINAL REFUSAL WRITTEN |
| Tuesday, April 12, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 12, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 13, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, October 13, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 13, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, September 23, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 23, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 23, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 19, 2021 | REFUSAL PROCESSED BY IB |
| Friday, March 26, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, March 25, 2021 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 23, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, March 22, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, March 18, 2021 | ASSIGNED TO EXAMINER |
| Friday, January 8, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, January 4, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 31, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |